MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE: BCR) today reported 2015 first quarter financial results. First quarter 2015 net sales were $819.7 million, an increase of 3 percent over the prior-year period on an as-reported basis. Excluding the impact of foreign exchange, first quarter 2015 net sales increased 5 percent over the prior-year period.
For the first quarter 2015, net sales in the U.S. were $574.1 million, an increase of 4 percent over the prior-year period. Net sales outside the U.S. were $245.6 million, a decline of 1 percent over the prior-year period on an as-reported basis. Excluding the impact of foreign exchange, first quarter 2015 net sales outside the U.S. increased 8 percent over the prior-year period.
For the first quarter 2015, net income was $139.8 million and diluted earnings per share were $1.82, a decrease of 6 percent and 2 percent, respectively, as compared to first quarter 2014 results. Adjusting for certain items that affect comparability between periods as detailed in the tables below, first quarter 2015 net income was $142.4 million and diluted earnings per share, after adjusting for certain items that affect comparability between periods and excluding amortization of intangible assets, were $2.10, an increase of 6 percent and 10 percent, respectively, as compared to first quarter 2014 results.
Timothy M. Ring, chairman and chief executive officer, commented, “Our results in the first quarter represented a good start to what is an important year of execution for us, as we once again exceeded our expectations for both sales and earnings per share. In 2015, we expect the returns from our strategic investment plan to begin to contribute to the improved long-term growth profile of the business.”
C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill, NJ, is a leading multinational developer, manufacturer and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology and surgical specialty products.
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current expectations, the accuracy of which is necessarily subject to risks and uncertainties. These statements are not historical in nature and use words such as “anticipate”, “estimate”, “expect”, “project”, “intend”, “forecast”, “plan”, “believe”, and other words of similar meaning in connection with any discussion of future operating or financial performance. Many factors may cause actual results to differ materially from anticipated results including product developments, sales efforts, income tax matters, the outcomes of contingencies such as legal proceedings, and other economic, business, competitive and regulatory factors. The company undertakes no obligation to update its forward-looking statements. Please refer to the Cautionary Statement Regarding Forward-Looking Information in our December 31, 2014 Form 10-K for more detailed information about these and other factors that may cause actual results to differ materially from those expressed or implied.
For full article, please click here.
Help employers find you! Check out all the jobs and post your resume.
